Similar content being viewed by others Introduction/background Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) are a class of medications increasingly utilized in the treatment of type 2 diabetes and, more recently, obesity (Nathan et al
The result is reduced appetite, lower food intake, and improved glycemic control
These services are elective wellness treatments and are not intended to diagnose, treat, cure, or prevent any medical condition or disease
HighFiber Foods Fiber is like a traffic controller for digestion
Issa, MD, PhD, is a dermatologist, medical director of research and academics at Forefront Dermatology, and professor at George Washington University
Wegovy (semaglutide) is a glucagon-like peptide-1 receptor agonist licensed for weight management in adults with obesity or overweight with comorbidities